EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access

What Determines the Clinical Course and Outcome of DPPX Encephalitis? A Systematic Review

Somdattaa Ray iD, Tinku Thomas, Vikram Kamath

Movement Disorders Clinical Practice · 2026-11 · 13 (11) · 2722-2732

DOI: 10.1002/mdc3.70694 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 29.05.2026. Verfasst von Somdattaa Ray und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St John's Medical College Hospital, Bangalore, India. Hauptthemen laut MEDLINE: Encephalitis, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, Immunotherapy. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dipeptidyl peptidase like protein 6 (DPPX) encephalitis is a rare type of autoimmune encephalitis. It presents with a plethora of clinical manifestations and variable disease course.

Objectives

The aim of this systematic review is to study the course of DPPX encephalitis, response to various immunotherapies and determine factors that can predict clinical outcome and relapse.

Methods

Search was performed in the PUBMED and Web of Science database for studies published until December 15, 2025. Univariate analysis and multiple regression modeling were used to analyze predictors affecting the outcome and relapse.

Results

Treatment details were available in 66 patients. Favorable clinical improvement was observed in 74.24% (n = 49) patients. Among these patients, 18 patients recovered completely with first line immunotherapy and short course of steroids with no relapse until the last follow up while 48 patients were treated with long term immunotherapy. Stratified multivariable regression analysis revealed that, among patients who lacked hyperekplexia, good response to first line immunotherapy (OR = 13.20, 95% CI = 1.89–91.91, p = 0.009) was associated with favorable clinical outcome. However, among patients with hyperekplexia, presence of good response to first line immunotherapy did not predict favorable outcome. CSF abnormality (OR = 14.00, 95% CI: 1.69–115.79, p = 0.02) and hyperekplexia (OR = 4.40, 95% CI: 1.37–14.11, p = 0.01) predicted higher propensity for relapse.

Conclusion

Recognition of hyperekplexia could be imperative in prognosticating patients with respect to need for long term immunotherapy and course of illness. This study also postulates the possibility of monophasic illness in a subgroup of patients with DPPX encephalitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EncephalitisDipeptidyl-Peptidases and Tripeptidyl-PeptidasesImmunotherapyHumansTreatment OutcomeNerve Tissue ProteinsPotassium Channels

Stichwörter der Autor:innen

autoimmune encephalitishyperekplexiaprognosis

Substanzen

Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesDPP6 protein, humanNerve Tissue ProteinsPotassium Channels

Autor:innen und Institutionen

  • Department of Neurology, St John's Medical College Hospital, Bangalore, India.
  • Department of Biostatistics, St. John's Medical College Hospital, Bangalore, India.
  • Department of Neurology, Trustwell Hospitals, Bangalore, India.

ORCID-Profile: Somdattaa Ray

Zitieren

APA

Ray, S., Thomas, T., & Kamath, V. (2026). What Determines the Clinical Course and Outcome of DPPX Encephalitis? A Systematic Review. Movement Disorders Clinical Practice, 13(11), 2722-2732. https://doi.org/10.1002/mdc3.70694

Vancouver

Ray S, Thomas T, Kamath V. What Determines the Clinical Course and Outcome of DPPX Encephalitis? A Systematic Review. Movement Disorders Clinical Practice. 2026;13(11):2722-2732. doi:10.1002/mdc3.70694

BibTeX
@article{Ray2026,
  author = {Ray, Somdattaa and Thomas, Tinku and Kamath, Vikram},
  title = {What Determines the Clinical Course and Outcome of DPPX Encephalitis? A Systematic Review},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {2722--2732},
  doi = {10.1002/mdc3.70694}
}
Kostenlos starten →